IP Library Granted Patent US 11,541,154
Granted Patent B2
US 11,541,154 · App. 13/827,790 · Granted Jan 3, 2023

Electrospun material covered medical appliances and methods of manufacture

Inventors: John William Hall (North Salt Lake, UT); Bart Dolmatch (Dallas, TX); Zeke Eller (Dallas, TX); Robert S. Kellar (Flagstaff, AZ); Rachel Lynn Simmons (Bountiful, UT); Wayne L. Mower (Bountiful, UT)
Assignee: Merit Medical Systems, Inc.
A61L31/148A61F2/82A61K9/70A61L27/16A61L27/34A61L27/56A61L31/048A61L31/10A61L31/146B05D1/007D01D5/0076D01F6/12D04H1/728D04H3/073A61F2/07A61F2002/30003A61F2002/3006A61F2002/30062A61F2002/30067A61F2002/30072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,541,154
App. No.
13/827,790
Granted
Jan 3, 2023
Kind
B2
Abstract

A medical appliance or prosthesis may comprise one or more layers of electrospun nanofibers, including electrospun polymers. The electrospun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Electrospun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis.

Claims (32)

1. A method for inhibiting a neointimal hyperplasia response to an implantable medical appliance, comprising implanting the medical appliance into a patient, the medical appliance coated with a first electrospun polytetrafluoroethylene (PTFE) layer comprising a porous mat and a second non electrospun polymer layer of fluorinated ethylene propylene (FEP) that is impervious to tissue ingrowth into the second polymer layer, wherein:

the implantable medical appliance comprises a tubular medical device;

the second polymer layer is disposed around the first electrospun PTFE layer;

the first electrospun PTFE layer defines an inside surface of the tubular medical device;

wherein the first electrospun PTFE layer is sintered,

wherein the second polymer layer is nonporous and non-fibrous,

wherein the medical appliance is coated with a third polymer layer comprising electrospun PTFE, such that the FEP is disposed between the first and third layers, and

wherein the combined thickness of the layers is between about 20 micrometers and 100 micrometers.

2. The method of claim 1 , wherein the first electrospun PTFE layer permits endothelial cell growth or attachment on the surface of the first electrospun PTFE layer.

3. The method of claim 1 , wherein the second polymer layer is a dip coating of FEP.

4. The method of claim 1 , wherein the second polymer layer is a spray coating of FEP.

5. The method of claim 1 , further comprising an ePTFE layer disposed around the second polymer layer.

6. The method of claim 1 , furthing comprising an ePTFE layer.

7. The method of claim 1 , wherein the second polymer layer partially coats of the first electrospun PTFE layer.

8. The method of claim 1 , wherein the first electrospun PTFE layer is produced by depositing PTFE fibers on a vertically oriented, rotating mandrel.

9. A method for inhibiting a neointimal hyperplasia response to an implantable medical appliance, comprising implanting the medical appliance into the vasculature of a patient, the medical appliance comprising a first electrospun PTFE layer, wherein the first electrospun PTFE layer is sintered, and a second non-electrospun polymer layer of fluorinated ethylene propylene (FEP) that is impervious to tissue ingrowth into the second polymer layer, wherein the implantable medical appliance is implanted such that the first electrospun PTFE layer is in contact with blood flowing through the patient's vasculature, wherein the second polymer layer is nonporous and non-fibrous, wherein the medical appliance is coated with a third polymer layer comprising electrospun PTFE, such that the FEP is disposed between the first and third layers, and wherein the combined thickness of the layers is between about 20 micrometers and 100 micrometers.

10. The method of claim 9 , wherein the first electrospun PTFE layer permits endothelial cell growth.

11. The method of claim 9 , wherein the second polymer layer is a dip coating of FEP.

12. The method of claim 9 , wherein the second polymer layer is a spray coating of FEP.

13. The method of claim 9 , wherein the second polymer layer is disposed around the first electrospun PTFE layer.

14. The method of claim 13 , wherein the first electrospun PTFE layer defines an inside surface of a tubular medical device.

15. The method of claim 14 , further comprising an ePTFE layer disposed around the first electrospun deposited PTFE layer.

16. The method of claim 9 , further comprising an ePTFE layer.

17. The method of claim 9 , wherein the second polymer layer partially coats of the first electrospun PTFE layer.

18. A method for inhibiting a neointimal hyperplasia response to an implantable medical appliance, comprising:

implanting the medical appliance into a patient, the medical appliance coated with a first electrospun polytetrafluoroethylene (PTFE) layer comprising a porous mat and a second non- electrospun polymer layer of fluorinated ethylene propylene (FEP) that is impervious to tissue ingrowth into the second polymer layer;

wherein the second polymer layer is disposed around the first electrospun PTFE

wherein the first electrospun PTFE layer defines an inside surface of the tubular medical device;

wherein the first electrospun PTFE layer is stretched,

wherein the second polymer layer is nonporous and non-fibrous,

wherein the medical appliance is coated with a third polymer layer comprising electrospun PTFE, such that the FEP is disposed between the first and third layers, and

wherein the combined thickness of the layers is between about 20 micrometers and 100 micrometers.

Assignments (2)
SECURITY INTEREST Recorded Aug 8, 2016
From: MERIT MEDICAL SYSTEMS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 039609/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2013
From: HALL, JOHN WILLIAM; DOLMATCH, BART; ELLER, ZEKE; KELLAR, ROBERT S.; SIMMONS, RACHEL LYNN; MOWER, WAYNE L.
To: MERIT MEDICAL SYSTEMS, INC.
Reel/Frame 030672/0372 →
Cited By (5)
US 12,396,837 US 12,440,606 US 12,672,951 US 12,691,671 US 12,691,672